SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kenji Taketani, Eriko Tokunaga, Nami Yamashita, Kimihiro Tanaka, Yoko Zaitsu, Hidetaka Yamamoto, Shinichi Aishima, Yoshinao Oda, Yasue Kimura, Masaru Morita, Yoshihiko Maehara, A case of ectopic breast carcinoma of the right axilla treated with neoadjuvant endocrine therapy, International Cancer Conference Journal, 2015, 4, 1, 29

    CrossRef

  2. 2
    Shinichiro Kashiwagi, Naoyoshi Onoda, Yuka Asano, Kento Kurata, Satoru Noda, Hidemi Kawajiri, Tsutomu Takashima, Masahiko Ohsawa, Seiichi Kitagawa, Kosei Hirakawa, Ambulatory sentinel lymph node biopsy preceding neoadjuvant therapy in patients with operable breast cancer: a preliminary study, World Journal of Surgical Oncology, 2015, 13, 1

    CrossRef

  3. 3
    Konstantinos Tryfonidis, Elzbieta Senkus, Maria J. Cardoso, Fatima Cardoso, Management of locally advanced breast cancer—perspectives and future directions, Nature Reviews Clinical Oncology, 2015, 12, 3, 147

    CrossRef

  4. 4
    Thanh U. Barbie, Cynthia Ma, Julie A. Margenthaler, Management of Premenopausal Women with Neoadjuvant Endocrine Therapy: A Single-Institution Experience, Annals of Surgical Oncology, 2015,

    CrossRef

  5. 5
    Frederico Leal, Vitor Teixeira Liutti, Vivian Castro Antunes dos Santos, Maximiliano Augusto Novis de Figueiredo, Ligia Traldi Macedo, José Augusto Rinck Junior, Andre Deeke Sasse, Neoadjuvant endocrine therapy for resectable breast cancer: A systematic review and meta-analysis, The Breast, 2015,

    CrossRef

  6. 6
    Laila S. Agrawal, Ingrid A. Mayer, Optimizing the Use of Neoadjuvant Endocrine Therapy, Current Oncology Reports, 2015, 17, 7

    CrossRef

  7. 7
    D. Groheux, E. Hindié, TEP/TDM au 18FDG dans le bilan initial et l’évaluation précoce de la chimiothérapie néoadjuvante du cancer du sein, Médecine Nucléaire, 2015, 39, 3, 315

    CrossRef

  8. 8
    M. Luque, F. Arranz, J. F. Cueva, A. de Juan, P. García-Teijido, L. Calvo, I. Peláez, A. García-Palomo, J. García-Mata, S. Antolín, L. García-Estévez, Y. Fernández, Breast cancer management in the elderly, Clinical and Translational Oncology, 2014, 16, 4, 351

    CrossRef

  9. 9
    Carlo Palmieri, Darren K. Patten, Adam Januszewski, Giorgia Zucchini, Sacha J. Howell, Breast cancer: Current and future endocrine therapies, Molecular and Cellular Endocrinology, 2014, 382, 1, 695

    CrossRef

  10. 10
    Veerabhadram Garimella, Tasadooq Hussain, Vijay Agarwal, Selvi Radhakrishna, John N. Fox, Peter J. Kneeshaw, Ervine D. Long, Tapan K. Mahapatra, Penelope L. McManus, Michael J. Lind, Philip J. Drew, Lynn Cawkwell, Clinical response to primary letrozole therapy in elderly patients with early breast cancer: Possible role for p53 as a biomarker, International Journal of Surgery, 2014, 12, 8, 821

    CrossRef

  11. 11
    Duveken B.Y. Fontein, Ayoub Charehbili, Johan W.R. Nortier, Elma Meershoek-Klein Kranenbarg, Judith R. Kroep, H. Putter, Yvonne van Riet, Grard A.P. Nieuwenhuijzen, Bart de Valk, Jetske M. Meerum Terwogt, Gijs D. Algie, Gerrit-Jan Liefers, Sabine Linn, Cornelis J.H. van de Velde, Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients – A phase II trial, European Journal of Cancer, 2014, 50, 13, 2190

    CrossRef

  12. 12
    J. M. Dixon, Endocrine Resistance in Breast Cancer, New Journal of Science, 2014, 2014, 1

    CrossRef

  13. 13
    Joohyun Woo, Woosung Lim, Endocrine Therapy for Breast Cancer, The Ewha Medical Journal, 2014, 37, 2, 83

    CrossRef

  14. 14
    Takayuki Ueno, Norikazu Masuda, Takeharu Yamanaka, Shigehira Saji, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Hironobu Sasano, Masakazu Toi, Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer, International Journal of Clinical Oncology, 2014, 19, 4, 607

    CrossRef

  15. 15
    Naruto Taira, Hiroji Iwata, Yoshie Hasegawa, Takehiko Sakai, Kenji Higaki, Kiyohiro Kihara, Takuhiro Yamaguchi, Shozo Ohsumi, Kojiro Shimozuma, Yasuo Ohashi, Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer, Breast Cancer Research and Treatment, 2014, 145, 1, 155

    CrossRef

  16. 16
    Elisa Vicini, Vikram Swaminathan, Riccardo Alberto Audisio, Management of breast cancer in elderly patients, Clinical Practice, 2014, 11, 1, 59

    CrossRef

  17. 17
    Marc Debled, Gaël Auxepaules, Christine Tunon de Lara, Delphine Garbay, Véronique Brouste, Emmanuel Bussières, Louis Mauriac, Gaëtan MacGrogan, Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making, The American Journal of Surgery, 2014, 208, 5, 756

    CrossRef

  18. 18
    A. Charehbili, D.B.Y. Fontein, J.R. Kroep, G.J. Liefers, J.S.D. Mieog, J.W.R. Nortier, C.J.H. van de Velde, Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review, Cancer Treatment Reviews, 2014, 40, 1, 86

    CrossRef

  19. 19
    Mediget Teshome, Kelly K. Hunt, Neoadjuvant Therapy in the Treatment of Breast Cancer, Surgical Oncology Clinics of North America, 2014, 23, 3, 505

    CrossRef

  20. 20
    C. Palmieri, S. Cleator, L. S. Kilburn, S. B. Kim, S.-H. Ahn, M. Beresford, G. Gong, J. Mansi, E. Mallon, S. Reed, K. Mousa, L. Fallowfield, M. Cheang, J. Morden, K. Page, D. S. Guttery, B. Rghebi, L. Primrose, J. A. Shaw, A. M. Thompson, J. M. Bliss, R. C. Coombes, NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer, Breast Cancer Research and Treatment, 2014, 148, 3, 581

    CrossRef

  21. 21
    Robert Carpenter, Julie C. Doughty, Carolyn Cordiner, Nuala Moss, Ashu Gandhi, Chris Wilson, Chris Andrews, Gillian Ellis, Gerald Gui, Anthony I. Skene, Optimum duration of neoadjuvant letrozole to permit breast conserving surgery, Breast Cancer Research and Treatment, 2014, 144, 3, 569

    CrossRef

  22. 22
    Jisun Kim, Woosung Lim, Eun-Kyu Kim, Min-Kyoon Kim, Nam-Sun Paik, Sang-Seol Jeong, Jung-han Yoon, Chan Park, Sei Ahn, Lee Kim, Sehwan Han, Seok Nam, Han-Sung Kang, Seung Kim, Young Yoo, Joon Jeong, Tae Kim, Taewoo Kang, Sung-Won Kim, Yongsik Jung, Jeong Lee, Ku Kim, Jong-Han Yu, Byung Chae, So-Youn Jung, Eunyoung Kang, Su Choi, Hyeong-Gon Moon, Dong-Young Noh, Wonshik Han, Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR), BMC Cancer, 2014, 14, 1, 170

    CrossRef

  23. 23
    Makoto Ishitobi, Osamu Suzuki, Yoshifumi Komoike, Shozo Ohsumi, Saki Nakahara, Toshinari Yagi, Tetsuhiro Yoshinami, Yasuhiko Tomita, Hideo Inaji, Phase II study of neoadjuvant anastrozole and concurrent radiotherapy for postmenopausal breast cancer patients, Breast Cancer, 2014, 21, 5, 550

    CrossRef

  24. 24
    Daisuke Shimizu, Takashi Ishikawa, Mikiko Tanabe, Takeshi Sasaki, Yasushi Ichikawa, Takashi Chishima, Itaru Endo, Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients, Breast Cancer, 2014, 21, 5, 557

    CrossRef

  25. 25
    Olivier Humbert, Alina Berriolo-Riedinger, Alexandre Cochet, Mélanie Gauthier, Céline Charon-Barra, Séverine Guiu, Isabelle Desmoulins, Michel Toubeau, Inna Dygai-Cochet, Charles Coutant, Pierre Fumoleau, François Brunotte, Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using 18F-FDG PET in luminal HER2-negative breast cancer, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 3, 416

    CrossRef

  26. 26
    Annie R Su, Mothaffar F Rimawi, Personalized Management of Breast Cancer, 2014,

    CrossRef

  27. 27
    Victoria Brown, Stephen Chan, Clinical Insights: Neoadjuvant Therapy in Breast Cancer, 2014,

    CrossRef

  28. 28
    Mark Beresford, Clinical Insights: Neoadjuvant Therapy in Breast Cancer, 2014,

    CrossRef

  29. 29
    Vladimir F Semiglazov, Vladislav V Semiglazov, Clinical Insights: Neoadjuvant Therapy in Breast Cancer, 2014,

    CrossRef

  30. 30
    Riccardo Soffietti, Elisa Trevisan, Roberta Rudà, Neurologic Aspects of Systemic Disease Part III, 2014,

    CrossRef

  31. 31
    Hiroji Iwata, Norikazu Masuda, Yasuaki Sagara, Takayuki Kinoshita, Seigo Nakamura, Yasuhiro Yanagita, Reiki Nishimura, Hirotaka Iwase, Shunji Kamigaki, Hiroyuki Takei, Hitoshi Tsuda, Nobuya Hayashi, Shinzaburo Noguchi, Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer , Cancer, 2013, 119, 4
  32. 32
    Y Delpech, C Coutant, L Hsu, E Barranger, T Iwamoto, C H Barcenas, G N Hortobagyi, R Rouzier, F J Esteva, L Pusztai, Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas, British Journal of Cancer, 2013, 108, 2, 285

    CrossRef

  33. 33
    David Groheux, Mathieu Hatt, Elif Hindié, Sylvie Giacchetti, Patricia de Cremoux, Jacqueline Lehmann-Che, Antoine Martineau, Michel Marty, Caroline Cuvier, Catherine Cheze-Le Rest, Anne de Roquancourt, Dimitris Visvikis, Marc Espié, Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors, Cancer, 2013, 119, 11
  34. 34
    R. Salmon, L. Ceugnart, J. Selz, C. Hennequin, F. Ettore, A. Gonçalves, Les traitements néoadjuvants TNA (RPC 2013), Oncologie, 2013, 15, 12, 607

    CrossRef

  35. 35
    P. K.-Y. Chang, S. Boridy, R. A. McKinney, D. Maysinger, Letrozole Potentiates Mitochondrial and Dendritic Spine Impairments Induced by β Amyloid, Journal of Aging Research, 2013, 2013, 1

    CrossRef

  36. 36
    Fausto Petrelli, Sandro Barni, Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer, Breast Cancer Research and Treatment, 2013, 142, 2, 227

    CrossRef

  37. 37
    E. Alba, L. Calvo, J. Albanell, J. R. De la Haba, A. Arcusa Lanza, J. I. Chacon, P. Sanchez-Rovira, A. Plazaola, J. A. Lopez Garcia-Asenjo, B. Bermejo, E. Carrasco, A. Lluch, Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study, Annals of Oncology, 2012, 23, 12, 3069

    CrossRef

  38. 38
    Manfred Kaufmann, Thomas Karn, Eugen Ruckhäberle, Controversies Concerning the Use of Neoadjuvant Systemic Therapy for Primary Breast Cancer, World Journal of Surgery, 2012, 36, 7, 1480

    CrossRef

  39. 39
    Rajiv C. Apsani, Shamir Chandran, Swee Tang Tieng, Beena C.R. Devi, First Asian Congress on Cancer in Older Patients Kuching, Malaysia 22–23rd January 2011, Journal of Geriatric Oncology, 2012, 3, 1, 68

    CrossRef

  40. 40
    Changhoon Yoo, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim, Hak-Hee Kim, Hee Jung Shin, Sei Hyun Ahn, Byung Ho Son, Gyungyub Gong, Impact of Immunohistochemistry-Based Molecular Subtype on Chemosensitivity and Survival in Patients with Breast Cancer Following Neoadjuvant Chemotherapy, Journal of Breast Cancer, 2012, 15, 2, 203

    CrossRef

  41. 41
    Florian Fitzal, Martina Mittlboeck, Guenther Steger, Rupert Bartsch, Margaretha Rudas, Peter Dubsky, Otto Riedl, Raimund Jakesz, Michael Gnant, Neoadjuvant Chemotherapy Increases the Rate of Breast Conservation in Lobular-Type Breast Cancer Patients, Annals of Surgical Oncology, 2012, 19, 2, 519

    CrossRef

  42. 42
    Alvaro Moreno-Aspitia, Neoadjuvant therapy in early-stage breast cancer, Critical Reviews in Oncology/Hematology, 2012, 82, 2, 187

    CrossRef

  43. 43
    A. M. Thompson, S. L. Moulder-Thompson, Neoadjuvant treatment of breast cancer, Annals of Oncology, 2012, 23, suppl 10, x231

    CrossRef

  44. 44
    Jennifer E. Joh, Nicole N. Esposito, John V. Kiluk, Christine Laronga, Nazanin Khakpour, Hatem Soliman, M. Catherine Lee, Pathologic Tumor Response of Invasive Lobular Carcinoma to Neo-adjuvant Chemotherapy, The Breast Journal, 2012, 18, 6
  45. 45
    Milvia Zambetti, Mauro Mansutti, Patricia Gomez, Ana Lluch, Christian Dittrich, Claudio Zamagni, Eva Ciruelos, Lorenzo Pavesi, Vladimir Semiglazov, Elena De Benedictis, Fernando Gaion, Mario Bari, Paolo Morandi, Pinuccia Valagussa, Gianni Luca, Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II), Breast Cancer Research and Treatment, 2012, 132, 3, 843

    CrossRef

  46. 46
    W. Grisold, G. Cavaletti, A. J. Windebank, Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention, Neuro-Oncology, 2012, 14, suppl 4, iv45

    CrossRef

  47. 47
    Antonio Llombart-Cussac, Ángel Guerrero, Antonio Galán, Vicente Carañana, Elvira Buch, Álvaro Rodríguez-Lescure, Amparo Ruiz, Carlos Fuster Diana, Vicente Guillem Porta, Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR[+] operable breast cancer, Clinical and Translational Oncology, 2012, 14, 2, 125

    CrossRef

  48. 48
    E. Jane Macaskill, J. Michael Dixon, Preoperative Endocrine Therapy: Preferred Therapy for Whom?, Current Breast Cancer Reports, 2012, 4, 1, 39

    CrossRef

  49. 49
    Jürgen Geisler, Ian Smith, William Miller, Presurgical (neoadjuvant) endocrine therapy is a useful model to predict response and outcome to endocrine treatment in breast cancer patients, The Journal of Steroid Biochemistry and Molecular Biology, 2012, 131, 3-5, 93

    CrossRef

  50. 50
    Manfred Kaufmann, Gunter von Minckwitz, Elefhterios P. Mamounas, David Cameron, Lisa A. Carey, Massimo Cristofanilli, Carsten Denkert, Wolfgang Eiermann, Michael Gnant, Jay R. Harris, Thomas Karn, Cornelia Liedtke, Davide Mauri, Roman Rouzier, Eugen Ruckhaeberle, Vladimir Semiglazov, W. Fraser Symmans, Andrew Tutt, Lajos Pusztai, Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer, Annals of Surgical Oncology, 2012, 19, 5, 1508

    CrossRef

  51. 51
    Tomoe Nakagawa, Koichi Sato, Minoru Moriwaki, Ryo Wada, Atsushi Arakawa, Mitsue Saito, Fujio Kasumi, Successful Endocrine Therapy for Locally Advanced Mucinous Carcinoma of the Breast, The Breast Journal, 2012, 18, 6
  52. 52
    Sindy Monnier, Jennifer Zakhireh, Laura J. Esserman, The Current Role of Endocrine Therapy in Locally Advanced Breast Cancer to Improve Breast Conservation Rates, Current Breast Cancer Reports, 2012, 4, 2, 139

    CrossRef

  53. 53
    Mohammad Mohammadianpanah, Yaghoub Ashouri, Sare Hoseini, Niloofar Amadloo, Abdolrasoul Talei, Sedigheh Tahmasebi, Hamid Nasrolahi, Ahmad Mosalaei, Shapour Omidvari, Mansour Ansari, Mohammad Amin Mosleh-Shirazi, The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial, Breast Cancer Research and Treatment, 2012, 132, 3, 853

    CrossRef

  54. 54
    David Groheux, Sylvie Giacchetti, Marc Espié, Domenico Rubello, Jean-luc Moretti, Elif Hindié, Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim, European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38, 3, 419

    CrossRef

  55. 55
    Saranya Chumsri, Angela Brodie, Endocrine Therapy in the Preoperative Setting and Strategies to Overcome Resistance, Current Breast Cancer Reports, 2011, 3, 4, 181

    CrossRef

  56. 56
    A. Berruti, D. Generali, M. Kaufmann, L. Puztai, G. Curigliano, M. Aglietta, L. Gianni, W. R. Miller, M. Untch, C. Sotiriou, M. Daidone, P. Conte, D. Kennedy, G. Damia, P. Petronini, S. Di Cosimo, P. Bruzzi, M. Dowsett, C. Desmedt, R. E. Mansel, L. Olivetti, C. Tondini, A. Sapino, P. Fenaroli, G. Tortora, H. Thorne, F. Bertolini, F. Ferrozzi, M. Danova, E. Tagliabue, E. de Azambuja, A. Makris, M. Tampellini, G. Dontu, L. Van't Veer, A. L. Harris, S. B. Fox, L. Dogliotti, A. Bottini, International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010), JNCI Monographs, 2011, 2011, 43, 147

    CrossRef

  57. You have full text access to this Open Access content57
    Masakazu Toi, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Masahiro Takada, Takayuki Ueno, Shigetoyo Saji, Niramol Chanplakorn, Takashi Suzuki, Hironobu Sasano, Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition, Cancer Science, 2011, 102, 4
  58. 58
    Luc Ceugnart, Bruno Coudert, Florence Dalenc, Jean-Marc Guinebretiere, Philippe Rouanet, Alain Toledano, Les traitements néoadjuvants (hors cancer du sein inflammatoire), Oncologie, 2011, 13, 10-11, 658

    CrossRef

  59. 59
    Ben Tran, Philippe L Bedard, Luminal-B breast cancer and novel therapeutic targets, Breast Cancer Research, 2011, 13, 6, 221

    CrossRef

  60. 60
    Hiroji Iwata, Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept, Breast Cancer, 2011, 18, 2, 92

    CrossRef

  61. 61
    Hiroyuki Takei, Masafumi Kurosumi, Takashi Yoshida, Yuji Hayashi, Toru Higuchi, Sayaka Uchida, Jun Ninomiya, Hanako Oba, Kenichi Inoue, Shigenori Nagai, Toshio Tabei, Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?, Breast Cancer, 2011, 18, 2, 85

    CrossRef

  62. 62
    Maryam B. Lustberg, Stephen P. Povoski, Weiqiang Zhao, Rebecca M. Ziegler, Yasuro Sugimoto, Amy S. Ruppert, Amy M. Lehman, Donna R. Shiels, Ewa Mrozek, Bhuvaneswari Ramaswamy, Rachel M. Layman, Robert W. Brueggemeier, Charles L. Shapiro, Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer, Clinical Breast Cancer, 2011, 11, 4, 221

    CrossRef

  63. 63
    Susan Hoover, Elizabeth Bloom, Sunil Patel, Review of Breast Conservation Therapy: Then and Now, ISRN Oncology, 2011, 2011, 1

    CrossRef

  64. 64
    Christopher Fosker, Julian W. Adlard, Abeer Shaaban, Tailoring Therapy for Locally Advanced Breast Cancer Using Molecular Profiles, Drugs, 2011, 71, 15, 1947

    CrossRef

  65. 65
    Abigail S Caudle, Kelly K Hunt, The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore, Current Opinion in Obstetrics and Gynecology, 2011, 23, 1, 31

    CrossRef

  66. 66
    Elgene Lim, Eric P Winer, Will preoperative trials change future clinical practice?, Clinical Investigation, 2011, 1, 1, 59

    CrossRef

  67. 67
    Lev M Berstein, Garik A Dashyan, Vladimir F Semiglazov, Advances in the Management of Triple Negative Breast Cancer, 2011,

    CrossRef

  68. 68
    Lev M Berstein, Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond, Future Oncology, 2010, 6, 8, 1313

    CrossRef

  69. 69
    Harry D. Bear, Neoadjuvant Chemotherapy for Operable Breast Cancer: Individualizing Locoregional and Systemic Therapy, Surgical Oncology Clinics of North America, 2010, 19, 3, 607

    CrossRef

  70. 70
    Jane S. Chawla, Cynthia X. Ma, Matthew J. Ellis, Neoadjuvant Endocrine Therapy for Breast Cancer, Surgical Oncology Clinics of North America, 2010, 19, 3, 627

    CrossRef

  71. 71
    Y H Chia, M J Ellis, C X Ma, Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool, British Journal of Cancer, 2010, 103, 6, 759

    CrossRef

  72. You have free access to this content72
    Stephen V. Liu, Laleh Melstrom, Kathy Yao, Christy A. Russell, Stephen F. Sener, Neoadjuvant therapy for breast cancer, Journal of Surgical Oncology, 2010, 101, 4
  73. 73
    Andres Forero-Torres, Mansoor N. Saleh, Janice A. Galleshaw, Cheryl F. Jones, Jatin J. Shah, Ivor J. Percent, Lisle M. Nabell, John T. Carpenter, Carla I. Falkson, Helen Krontiras, Marshall M. Urist, Kirby I. Bland, Jennifer F. De Los Santos, Ruby F. Meredith, Valerie Caterinicchia, Wanda K. Bernreuter, Janis P. O'Malley, Yufeng Li, Albert F. LoBuglio, Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor— or Progesterone Receptor—Positive Breast Cancer, Clinical Breast Cancer, 2010, 10, 4, 275

    CrossRef

  74. 74
    Georgia M. Beasley, John A. Olson, What's New in Neoadjuvant Therapy for Breast Cancer?, Advances in Surgery, 2010, 44, 1, 199

    CrossRef

  75. 75
    A Barnadas, M Gil, S González, I Tusquets, M Muñoz, A Arcusa, L Prieto, M Margelí-Vila, A Moreno, Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial, British Journal of Cancer, 2009, 100, 3, 442

    CrossRef

  76. 76
    J. Mathew, K.S. Asgeirsson, K.L. Cheung, S. Chan, A. Dahda, J.F.R. Robertson, Neoadjuvant chemotherapy for locally advanced breast cancer: A review of the literature and future directions, European Journal of Surgical Oncology (EJSO), 2009, 35, 2, 113

    CrossRef

  77. 77
    J. Mathew, K.S. Asgeirsson, L.R. Jackson, K.L. Cheung, J.F.R. Robertson, Neoadjuvant endocrine treatment in primary breast cancer – Review of literature, The Breast, 2009, 18, 6, 339

    CrossRef

  78. 78
    Zsuzsanna Kahán, Aliz Nikolényi, Gabriella Uhercsák, László Thurzó, Neoadjuvant systemic therapy in breast cancer, Orvosi Hetilap, 2009, 150, 2, 65

    CrossRef

  79. 79
    Ricardo Brugés, Luis Hernán Guzmán, Oswaldo Sánchez, Sandra Díaz, Édgar Vergara, Neoadyuvancia en cáncer de mama, Revista Colombiana de Cancerología, 2009, 13, 3, 157

    CrossRef

  80. 80
    Johanna G. H. van Nes, Hein Putter, Jean-Pierre Julien, Michelle Tubiana-Hulin, Marc van de Vijver, Jan Bogaerts, Monika de Vos, Cornelis J. H. van de Velde, Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902, Breast Cancer Research and Treatment, 2009, 115, 1, 101

    CrossRef

  81. 81
    A. U. Buzdar, Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer, Annals of Oncology, 2009, 20, 6, 993

    CrossRef

  82. 82
    C. H. Barrios, C. Sampaio, J. Vinholes, R. Caponero, What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?, Annals of Oncology, 2009, 20, 7, 1157

    CrossRef

  83. 83
    S Moulder, G N Hortobagyi, Advances in the Treatment of Breast Cancer, Clinical Pharmacology & Therapeutics, 2008, 83, 1
  84. 84
    Juan De la Haba-Rodriguez, Emilio Alba, Agustí Barnadas, Eloisa Bayo, Antonio Llombart, Ana Lluch, Miguel Martín, José Andrés Moreno-Nogueira, Gumersindo Pérez Manga, Álvaro Rodríguez-Lescure, Enrique Aranda, Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007, Clinical and Translational Oncology, 2008, 10, 9, 552

    CrossRef

  85. 85
    Eleftherios P. Mamounas, Facilitating Breast-Conserving Surgery and Preventing Recurrence: Aromatase Inhibitors in the Neoadjuvant and Adjuvant Settings, Annals of Surgical Oncology, 2008, 15, 3, 691

    CrossRef

  86. 86
    Nagi S. El Saghir, Alexandru Eniu, Robert W. Carlson, Zeba Aziz, Daniel Vorobiof, Gabriel N. Hortobagyi, Locally advanced breast cancer, Cancer, 2008, 113, S8
  87. 87
    Agustí Barnadas, Miguel Gil, Pedro Sánchez-Rovira, Antonio Llombart, Encarna Adrover, Laura G. Estevez, Juan de la Haba, Lourdes Calvo, Neoadjuvant endocrine therapy for breast cancer: past, present and future, Anti-Cancer Drugs, 2008, 19, 4, 339

    CrossRef

  88. 88
    Rosalba Torrisi, Silvia Dellapasqua, Raffaella Ghisini, Giuseppe Viale, Paolo Veronesi, Alberto Luini, Mattia Intra, Giulia Peruzzotti, Andrea Rocca, Alessandra Balduzzi, Anna Cardillo, Aron Goldhirsch, Marco Colleoni, Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors, The Breast, 2008, 17, 6, 654

    CrossRef

  89. 89
    Christos Markopoulos, Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor, Surgical Oncology, 2008, 17, 2, 113

    CrossRef

  90. 90
    Scientific surgery, British Journal of Surgery, 2007, 94, 11